Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The application of organic solid-liquid phase change materials (PCMs) is limited for the leakage problem after phase change and high rigidity. In this work, a novel flexible solid-solid PCM (DXPCM) was synthesized using a block copolymerization process with polyethylene glycol (PEG) as the energy storage segment. The phase transition temperature (from 36.2 to 49.4 °C) and enthalpy (from 83.27 to 123.35 J/g) of DXPCM could be changed through adjusting the molecular weight of PEG. The introduction of hard chain segments endowed DXPCM with excellent flexibility, foldability, and mechanical properties at room temperature. The large number of internal hydrogen bonds and π-π stacking provided DXPCM with interesting thermally induced switchable adhesion and recyclability. The storage and release of elastic potential energy ensured that DXPCM could recover its original shape after being deformed by external forces. It is worth mentioning that DXPCM exhibits excellent infrared stealth capability as it can absorb and release latent heat for a long period of time. In conclusion, this work developed a novel solid-solid phase change film with high mechanical strength, thermally induced switchable adhesion, and shape recovery capability, which has great potential for application in infrared stealth.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.4c18276DOI Listing

Publication Analysis

Top Keywords

phase change
16
thermally induced
12
induced switchable
12
switchable adhesion
12
infrared stealth
12
high mechanical
8
mechanical strength
8
strength thermally
8
adhesion shape
8
dxpcm
6

Similar Publications

BackgroundTherapeutic plasma exchange (TPE) with albumin replacement has emerged as a potential treatment for Alzheimer's disease (AD). The AMBAR trial showed that TPE could slow cognitive and functional decline, along with changes in core and inflammatory biomarkers in cerebrospinal fluid.ObjectiveTo evaluate the safety and effectiveness of TPE in a real-world setting in Argentina.

View Article and Find Full Text PDF

Importance: This study represents a first successful use of a genetic biomarker to select potential responders in a prospective study in psychiatry. Liafensine, a triple reuptake inhibitor, may become a new precision medicine for treatment-resistant depression (TRD), a major unmet medical need.

Objective: To determine whether ANK3-positive patients with TRD benefit from a 1-mg and/or 2-mg daily oral dose of liafensine, compared with placebo, in a clinical trial.

View Article and Find Full Text PDF

The human auditory system must distinguish relevant sounds from noise. Severe hearing loss can be treated with cochlear implants (CIs), but how the brain adapts to electrical hearing remains unclear. This study examined adaptation to unilateral CI use in the first and seventh months after CI activation using speech comprehension measures and electroencephalography recordings, both during passive listening and an active spatial listening task.

View Article and Find Full Text PDF

Recent studies have shown that the glymphatic system plays a crucial role in driving hyperacute edema after ischemic stroke. This has sparked interest in understanding how this system changes in later phases of ischemic stroke. In this study, we utilized cisternal contrast-enhanced magnetic resonance imaging (CE-MRI) and immunofluorescence staining to investigate glymphatic system alterations at subacute and chronic phases of ischemic stroke.

View Article and Find Full Text PDF

Objectives: To evaluate the association between the KRAS mutational load and the histologic tumor response in patients with resectable pancreatic ductal adenocarcinoma (PDAC) who received neoadjuvant treatment (NAC) with pegylated liposomal irinotecan in combination with oxaliplatin, 5-fluorouracil, and leucovorin (NALIRIFOX).

Methods: This was a multicenter, single-arm, interventional, open-label, phase 2 trial in patients 18 years or older who had histologically or cytologically confirmed PDAC and were candidates for surgery and received neoadjuvant NALIRIFOX. The primary outcome was determination of the association between the KRAS mutational load and the histologic tumor response after chemotherapy.

View Article and Find Full Text PDF